A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04564001` - Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis	Phase 2
Completed	`NCT03750929` - Aerobic Capacity and Strength Exercise in Takayasu's Arteritis	N/A
Recruiting	`NCT04137614` - Drug-coated Balloon for Takayasu Arteritis Associated Renal Artery Stenosis	N/A
Recruiting	`NCT02967068` - VCRC Tissue Repository
Recruiting	`NCT05102448` - Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis	Phase 4
Recruiting	`NCT03893136` - The Registry Study of Takayasu Arteritis in East China
Active, not recruiting	`NCT00006055` - Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases	N/A
Completed	`NCT03096275` - Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis	Phase 3
Recruiting	`NCT04299971` - Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients	Phase 4
Recruiting	`NCT04300686` - A Pilot Study in Severe Patients With Takayasu Arteritis.	Phase 4
Recruiting	`NCT03192878` - Infliximab Biosimilar in Takayasu's Arteritis	N/A
Active, not recruiting	`NCT04071691` - PET Imaging of Giant Cell and Takayasu Arteritis
Recruiting	`NCT05904301` - Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
Completed	`NCT02101333` - Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis	Phase 3
Not yet recruiting	`NCT03550781` - Anti-inflammatory Treatment for Inactive Takayasu Arteritis	Phase 2/Phase 3
Active, not recruiting	`NCT05168475` - Biologics in Refractory Vasculitis	Phase 2
Completed	`NCT03956394` - Takayasu Arteritis Activity Evaluation by Ultrafast Ultrasound Imaging	N/A
Recruiting	`NCT05151848` - Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis	Phase 4
Completed	`NCT03430388` - Yellow Fever Vaccine in Patients With Rheumatic Diseases	N/A
Completed	`NCT02925351` - Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases	Early Phase 1

NCT number	NCT04882072
Study type	Interventional
Source	Janssen Pharmaceutical K.K.
Contact
Status	Terminated
Phase	Phase 3
Start date	September 15, 2021
Completion date	May 25, 2023

A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms